Question 1

What are the potential side effects of Valcyte for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age clinical trial (NCT01165580). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this study compare to other treatments for CMV?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age clinical trial (NCT01165580). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will be done during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age clinical trial (NCT01165580). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will my child need to participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age clinical trial (NCT01165580). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my child experiences side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age clinical trial (NCT01165580). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any other treatment options available for my child's condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age clinical trial (NCT01165580). Contact the study team or your healthcare provider for specific answers.

What this study is about